BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16231974)

  • 1. Differential recruitment of pre-mRNA splicing factors to alternatively spliced transcripts in vivo.
    Mabon SA; Misteli T
    PLoS Biol; 2005 Nov; 3(11):e374. PubMed ID: 16231974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
    Wang J; Manley JL
    RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of SRp20 exon 4 splicing.
    Jumaa H; Nielsen PJ
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
    Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
    J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
    Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
    RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear pre-mRNA compartmentalization: trafficking of released transcripts to splicing factor reservoirs.
    Melcák I; Cermanová S; Jirsová K; Koberna K; Malínský J; Raska I
    Mol Biol Cell; 2000 Feb; 11(2):497-510. PubMed ID: 10679009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements.
    Mayeda A; Screaton GR; Chandler SD; Fu XD; Krainer AR
    Mol Cell Biol; 1999 Mar; 19(3):1853-63. PubMed ID: 10022872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
    Jumaa H; Nielsen PJ
    EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.
    Blanco FJ; Bernabeu C
    Aging Cell; 2011 Oct; 10(5):896-907. PubMed ID: 21668763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
    Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
    Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of alternative splicing within the supraspliceosome.
    Sebbag-Sznajder N; Raitskin O; Angenitzki M; Sato TA; Sperling J; Sperling R
    J Struct Biol; 2012 Jan; 177(1):152-9. PubMed ID: 22100336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASF.
    Sanford JR; Coutinho P; Hackett JA; Wang X; Ranahan W; Caceres JF
    PLoS One; 2008 Oct; 3(10):e3369. PubMed ID: 18841201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
    Dauksaite V; Akusjärvi G
    J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
    D'Souza I; Schellenberg GD
    J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular anatomy of a speckle.
    Hall LL; Smith KP; Byron M; Lawrence JB
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Jul; 288(7):664-75. PubMed ID: 16761280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A.
    Qian W; Liang H; Shi J; Jin N; Grundke-Iqbal I; Iqbal K; Gong CX; Liu F
    Nucleic Acids Res; 2011 Aug; 39(14):6161-71. PubMed ID: 21470964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotranscriptional recruitment of yeast TRAMP complex to intronic sequences promotes optimal pre-mRNA splicing.
    Kong KY; Tang HM; Pan K; Huang Z; Lee TH; Hinnebusch AG; Jin DY; Wong CM
    Nucleic Acids Res; 2014 Jan; 42(1):643-60. PubMed ID: 24097436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.